MetLife stock (ticker MET) experienced a decline of 2.68% in May 2026, trading at $78.08 as of early in the month according to data from StockTitan. Algorithmic analysis identified bearish positioning and mid-channel oscillation patterns, with weak near-term sentiment potentially catalyzing further downward pressure on the price. This recent movement reflects broader market dynamics affecting major US insurers, though the company maintains a top-tier position within the sector with a market capitalization of approximately $50 billion.
The article outlines MetLife's business model which relies on underwriting discipline, investment income from its general account, and fee-based revenues. Its primary segments include Group Benefits for US employers covering dental, disability, accident, and life insurance; Retirement and Income Solutions through annuities; and foundational Life Insurance products. Geographically, the US segment contributes the largest share of premiums, while Asia offers growth potential, and MetLife utilizes technology and AI-driven underwriting to maintain competitive edges.
The company operates with a significant presence in core markets including the United States, Asia, Europe, Middle East, Africa (EMEA), and Latin America. The business benefits from demographic trends such as aging populations and leverages higher interest rates to boost investment yields, although it faces challenges from rising premiums driven by inflation and catastrophe risks. MetLife's competitive moat is built on brand trust and extensive distribution networks, and the stock offers defensive qualities to portfolios sensitive to Federal Reserve policies regarding interest rates.
While short-term sentiment remains challenged, the analysis notes that MetLife's robust US-centric model and diversified revenue streams provide a degree of resilience in the insurance landscape. The company continues to adapt to sector trends including ESG integration and the need for cyber risk coverage through sustainable investment portfolios. Investors are advised to monitor rate environments and economic indicators as these factors will continue to shape the stock's trajectory alongside broader market pressures affecting peers like Allstate and Prudential.
📉 MetLife shares dropped 2.68% in May, trading at $78.08 amid bearish positioning.
🛡️ Global insurance leader driven by Group Benefits and retirement income solutions.
💰 Leverages AI technology and holds $50B market cap with stable dividends.
📉 MetLife shares declined 2.68% in May 2026, trading at $78.08 as of early May according to StockTitan data.
🛡️ MetLife operates as a global leader in insurance, annuities, and employee benefit programs with significant US market exposure.
🏢 Group Benefits is a primary revenue driver covering dental, disability, accident, and life insurance for millions of US workers.
📅 Retirement and Income Solutions, including annuities, provide steady income streams and appeal to investors seeking defensive assets.
🌍 The company's geographic presence includes the US as its largest premium source, with Asia offering growth potential through expanding middle-class demand.
💰 Investment income from the general account and fee-based revenues enhance margins during favorable interest rate environments.
⚖️ MetLife maintains a top-tier position among peers like Allstate and Prudential with a market capitalization around $50 billion.
🤖 The insurer leverages AI-driven underwriting technology to maintain competitive edges and supports digital transformation efforts.
🌱 ESG integration and cyber risk coverage are key trends shaping the sector, which MetLife addresses through sustainable investment portfolios.
🏦 As a NYSE-listed stock, MetLife offers dividend stability and sensitivity to Federal Reserve policies regarding interest rates.
💼 The company serves individual and institutional customers across segments including the US, Asia, Latin America, Europe, and EMEA.
⚠️ Rising premiums due to inflation and catastrophe risks present industry-wide challenges that MetLife must navigate.
📊 Employment trends are mirrored in the stock's performance via its group benefits segment, acting as a barometer for economic health.
👉 Investors continue to monitor rate environments and broader economic indicators while assessing short-term market pressures.
⚠️ The article includes a disclaimer noting that stocks are volatile financial instruments and the content does not constitute investment advice.
Bullish Signals
MetLife is a global leader in insurance with a strong US focus.
Ticker MET trades on NYSE, key for US retail investors.
Group Benefits drives revenue via dental and life coverage for millions.
Annuities offer steady income streams appealing to defensive investors.
Asia expansion targets growing middle-class demand.
Market cap reached around $50 billion in May 2026.
AI-driven underwriting maintains competitive edges against digital rivals.
ESG principles and cyber coverage adapt to sector trends.
Stock provides dividend stability for volatile markets.
Higher interest rates boost investment yields and margins.
Risk Factors
Shares dropped 2.68% in May 2026 trading at $78.08.
Weekly sentiment weak and bearish positioning may catalyze decline.
Inflation and catastrophe risks drive rising operational premiums.
Stock volatility exposed to unfavorable Federal Reserve rate shifts.
Bullish Signals
MetLife operates as one of the largest providers of insurance, annuities, and employee benefit programs globally, with a strong emphasis on the US market.
The company maintains a significant presence on the NYSE under the ticker MET, making it a key player for US retail investors tracking the insurance sector.
Group Benefits represents a primary revenue driver, contributing through dental, disability, accident, and life coverage for US employers where it covers millions of workers.
Retirement and Income Solutions, including annuities, provide steady income streams, appealing to US investors seeking defensive assets.
Asia provides growth potential through expanding middle-class demand, offering an outlet for the company's expansion strategies.
MetLife holds a top-tier position among peers like Allstate and Prudential, with a market cap reflecting its scale at around $50 billion as of May 2026.
The company invests in AI-driven underwriting to maintain competitive edges against digital transformation efforts by competitors.
MetLife adapts to sector trends through sustainable investment portfolios, integrating ESG principles and cyber risk coverage.
The stock offers dividend stability and acts as a defensive asset for domestic portfolios during market volatility.
Higher interest rates are currently boosting investment yields, which enhances margins in the company's business model.
Risk Factors
MetLife shares experienced a notable decline, dropping 2.68% in May 2026 to trade at $78.08, indicating weakening investor sentiment.
Algorithmic analysis highlights weak near-term sentiment and mid-channel oscillation patterns that could catalyze further bearish positioning for the stock.
The company faces rising operational premiums driven by inflation and increasing catastrophe risks within the US insurance market.
MetLife's performance is highly sensitive to Federal Reserve policies on interest rates, exposing the stock to volatility if rate environments shift unfavorably.
MetLife (NYSE:MET) reported a robust start to its financial year in 2026, with the company highlighting broad-based growth across operating businesses and favorable underwriting trends under its New Frontier strategy. Adjusted earnings for the quarter came in at $1.6 billion, or $2.42 per share, representing an 18% increase from the prior year period, while adjusted earnings per share climbed 23%. The stronger adjusted results were partly attributed to disciplined capital management, although net investment losses from normal trading activity and a modest loss on private equity sales caused reported net income to be lower at $1.1 billion or $1.74 per share. Revenue grew 10% year-over-year excluding pension risk transfers, and return on equity hit the top end of its target range at 17%.
Within specific business segments, Group Benefits saw adjusted earnings rise 19% to $439 million, driven by exceptional life mortality which came in at 80.1%, surpassing its target range of 83% to 88%. Executives noted that this favorability could be influenced by factors such as GLP-1 drugs and potential post-pandemic effects, with MetLife planning to gradually adjust pricing if these trends continue. Retirement and Income Solutions reported an 11% increase in adjusted earnings to $451 million, supported by higher variable investment income and favorable margins, while the company maintains a full-year guidance of $1.6 billion to $1.8 billion for this segment.
International operations also delivered significant growth, with Asia's adjusted earnings surging 31% to $487 million. This expansion was led by strong performance in Japan and Korea; Japan sales increased 26% on a constant currency basis due to a mix of product launches and strength in both yen and dollar products, while Korean sales grew 44% driven by U.S. dollar products. Latin America saw earnings rise 5% year-over-year despite a tax-related headwind in Mexico, and EMEA adjusted earnings jumped 33%, with the company stating that recent geopolitical tensions in the Middle East have not yet had a material impact on its overall operations.
On the investment side, MetLife Investment Management reported an 89% increase in adjusted earnings to $47 million following the first fully integrated quarter after acquiring PineBridge. While institutional client outflows of approximately $2 billion occurred during the quarter due to market volatility and allocation shifts, management indicated that these flows had stabilized later in the quarter and that the pipeline for private assets remained strong. The company is continuing its integration of the two platforms to leverage business growth and favorable expense margins from the combined entity.
📈 Adjusted earnings rose 18% to $1.6B despite net investment losses.
💰 Group Benefits and RIS divisions posted double-digit adjusted earnings growth.
🌏 International Asia and EMEA businesses drove revenue expansion significantly.
⚙️ Strategic capital management under the New Frontier strategy fuels growth.
📈 MetLife reported strong Q1 2026 results with adjusted earnings of $1.6 billion ($2.42/share), an 18% increase from the prior year.
💰 Net income was $1.1 billion ($1.74/share), primarily affected by net investment losses from normal trading and a partial private equity sale.
📊 Adjusted revenue excluding pension risk transfers rose 10%, while return on equity reached 17% at the top end of its target range.
💼 Group Benefits adjusted earnings surged 19% to $439 million, driven by exceptional life mortality and favorable working population trends.
💊 Analysts noted potential mortality drivers like GLP-1 drugs could lead to gradual pricing adjustments if favorability persists long-term.
🏦 Retirement and Income Solutions (RIS) adjusted earnings grew 11% to $451 million, boosted by higher variable investment income and favorable underwriting.
🌏 International businesses showed broad growth, with Asia earning $487 million (up 31%) led by strong sales in Japan and Korea.
📉 Latin America earnings were $229 million but down 9% on a constant currency basis due to tax changes in Mexico.
🚀 EMEA adjusted earnings jumped 33% to $110 million as multi-year sales growth translated into premium increases.
🏢 MetLife Investment Management (including PineBridge) earned $47 million in its first fully integrated quarter, exceeding February outlooks.
💸 Institutional outflows of about $2 billion were observed due to market volatility and platform integration, though the pipeline remains strong.
🇯🇵 Japan sales rose 26% on a constant currency basis, highlighted by a new corporate accident and health product launch.
💰 Korea sales increased 44%, supported by strength in both U.S. dollar and Korean won products amid rising equity markets.
🌍 MetLife stated that current geopolitical situations in the Middle East have not materially impacted EMEA or the company overall.
⚙️ Management emphasized disciplined capital management under its New Frontier strategy as a key driver of top-line growth across all segments.
Bullish Signals
Adjusted earnings rose 18% to $1.6 billion for Q1.
EPS surged 23% to $2.42 via disciplined capital management.
Group Benefits earnings grew 19% on strong mortality ratios.
Group Benefits sales jumped 15% with double-digit voluntary growth.
RIS earnings increased 11% supported by top-end investment spread.
Asia adjusted earnings expanded 31% and Latin America sales up 20%.
Japan sales surged 77% while Korea grew 44%.
PineBridge investment management achieved integrated quarter with $47m earnings.
Outflows stabilized with strong private asset forward commitments.
Risk Factors
MetLife recorded net investment losses from trading activity and private equity sales.
Direct expense ratio at 11.9% remains above the 2026 target of 12.1%.
Core spread declined 4 basis points following asset rotations for pension inflows.
Latin America adjusted earnings dropped 9% due to tax changes in Mexico.
Institutional outflows reached $2 billion driven by volatility and allocation shifts.
Favorable mortality trends may be temporary pull-forward effects rather than structural.
Bullish Signals
MetLife reported adjusted earnings of $1.6 billion for Q1, representing an 18% year-over-year increase driven by broad-based growth across all operating businesses.
Adjusted earnings per share surged 23% to $2.42, reflecting the full earnings power of the company and disciplined capital management under the New Frontier strategy.
Group Benefits adjusted earnings grew 19% to $439 million, aided by exceptional life mortality ratios of 80.1%, which outperformed the annual target range of 83% to 88%.
Group Benefits sales increased 15% driven by double-digit growth in voluntary products and improved persistency, particularly in dental lines.
Retirement and Income Solutions (RIS) delivered adjusted earnings up 11% to $451 million, supported by a total investment spread of 119 basis points at the top end of guidance.
International businesses demonstrated robust expansion with Asia adjusted earnings rising 31% and Latin America sales growing 20% on a constant currency basis.
Asia region sales grew 22% led by strong performance in Japan, where accident and health sales surged 77%, and Korea, which saw a 44% increase in sales.
MetLife Investment Management achieved its first fully integrated quarter after the PineBridge acquisition with adjusted earnings up to $47 million.
Outflows in the investment management business stabilized later in the quarter, and forward commitments remained strong particularly within private assets.
Risk Factors
MetLife incurred net investment losses primarily due to normal trading activity within its fixed maturity portfolio, along with a modest loss tied to the sale of private equity limited partnership interests.
The direct expense ratio improved to 11.9%, which is still above the company's 2026 annual target of 12.1%.
Core spread excluding variable investment income decreased by 4 basis points sequentially as MetLife rotated assets tied to large fourth-quarter pension risk transfer inflows.
Latin America adjusted earnings declined 9% on a constant currency basis, caused by Mexico's value-added tax change and less favorable taxes.
Institutional client outflows amounted to approximately $2 billion during the quarter, driven by market volatility, normal allocation shifts, and integration effects between MetLife and PineBridge.
Potential drivers of favorable mortality trends, such as GLP-1 drugs, may be temporary pull-forward effects rather than sustainable structural changes.
MetLife (MET) shares have recently appreciated by 10.7%, yet Simply Wall St's Excess Returns model suggests the stock remains undervalued at approximately a 57% discount to its intrinsic value of $183.78 per share, based on a recent market price of around $78.82 and a stable book value estimate of $58.06. The analysis utilizes weighted future Return on Equity estimates from eight analysts projecting an average return of 15.86% against a cost of equity, resulting in calculated excess returns that drive the high intrinsic value figure. While traditional metrics like the Price-to-Earnings ratio show the stock trading at 14.81x earnings, which is slightly above the insurance industry and peer averages but nearly identical to Simply Wall St's proprietary Fair Ratio of 14.91x, the valuation gap in the Excess Returns model indicates a significant potential opportunity according to this specific framework. The article highlights that while narrative factors such as international growth or digital transformation could support higher valuations like the $102 analyst target, concerns regarding interest rates and credit risks might anchor expectations closer to the $75 target, illustrating how different investment stories translate into varying fair value estimates.
The content focuses specifically on providing a fundamental data-driven analysis of MetLife's valuation rather than acting as a general market overview or financial advice. It distinguishes between broad industry P/E comparisons and the company-specific Fair Ratio tailored to MetLife's own fundamentals, while emphasizing that its methodology uses historical data and analyst forecasts without factoring in latest price-sensitive announcements. The article concludes with standard disclosures regarding the use of unbiased methodology, the non-advise nature of the commentary, and Simply Wall St's lack of position in the stock, directing readers toward a detailed Company Report for further insights into dividends, insider trades, and financial conditions.
📈 Shares gained 10.7% recently but trail at 3.8% total annual return.
💸 Valuation models suggest a massive 57.1% discount to the current price of $78.82.
⚠️ Trading above industry peers, key risks include interest rates and credit quality.
📉 MetLife shares have recently gained 10.7% but only delivered a 3.8% total return over the last year.
🧮 An Excess Returns model calculates an intrinsic value of $183.78 per share for MetLife.
💸 The current market price is approximately $78.82, suggesting a 57.1% discount to the model's estimate.
📊 MetLife trades at a Price-to-Earnings (P/E) ratio of 14.81x based on current earnings.
🔍 This P/E multiple is higher than both the Insurance industry average (11.18x) and the peer group average (13.20x).
⚖️ Simply Wall St's proprietary Fair Ratio suggests a reasonable P/E of 14.91x, nearly identical to the current price.
🗣️ Investor narratives regarding fair value vary widely, ranging from $75 to $102 per share depending on risk factors and growth potential.
⚠️ The analysis highlights considerations such as interest rates, credit risk, technology execution, and international growth opportunities.
📝 This article utilizes historical data and analyst forecasts without constituting specific financial advice or a recommendation to buy.
Stock trades at 57.1% discount to intrinsic value.
P/E of 14.81x exceeds industry average of 11.18x.
Risk Factors
Market narrative anchors fair value near US$75 due to interest rate, credit risk, and tech execution concerns.
MetLife trades at 14.81x P/E, above the 11.18x industry average and 13.20x peer group averages.
Valuations cite risks of interest rate sensitivity and potential credit quality deterioration.
Bullish Signals
MetLife delivered strong 3.8% returns over the last year, demonstrating performance that competes favorably with the broader Insurance industry.
Based on an Excess Returns model using a book value of $41.69 and stable earnings per share estimate of $9.21, MetLife is estimated to have an intrinsic value of approximately $183.78 per share.
This analysis suggests MetLife is trading at a significant 57.1% discount compared to the recent share price of around $78.82, indicating substantial upside potential.
MetLife trades on a P/E ratio of 14.81x, which is above both the Insurance industry average of 11.18x and the peer group average of 13.20x, suggesting a quality valuation.
Simply Wall St's proprietary Fair Ratio estimate of 14.91x closely aligns with the current P/E of 14.81x, confirming the stock is priced at a fair level based on its specific fundamentals.
Risk Factors
The article explicitly notes that one market narrative anchors MetLife's fair value near the US$75 analyst target due to concerns regarding interest rates, credit risk, and technology execution.
MetLife trades at a P/E of 14.81x, which is above the Insurance industry average of 11.18x and the peer group average of 13.20x, suggesting a potentially richer valuation compared to sector benchmarks.
Analyst forecasts vary widely, with some valuations tied to US$75 specifically citing risks related to interest rate sensitivity and potential credit quality deterioration.
MetLife Stadium in East Rutherford, New Jersey, is currently undergoing installation of a natural grass surface in preparation for hosting eight matches during the upcoming FIFA World Cup, including the final scheduled for July 19. This marks a significant change for the venue, which traditionally utilizes an artificial turf field and houses NFL teams like the New York Giants and Jets. To accommodate the soccer pitch, organizers removed 1,740 seats from the stadium's corners to create necessary space for a longer run-up area required for corner kicks.
The installation process, led by FIFA Senior Pitch Manager David Graham, involved laying down approximately 600 rolls of grass grown in North Carolina on a base layer composed of sand, a permeable cloth called Permavoid, and a ventilation layer. Workers completed the initial phase of installation late on Wednesday night despite minor weather delays, with plans to finish the remainder by late Thursday. This natural grass surface, known as Bermuda grass, is being used alongside other venues in warm climates such as Miami Gardens, Kansas City, and Guadalajara for the expanded 48-nation tournament featuring 104 games across 11 sites in the U.S., Mexico, and Canada.
MetLife Stadium's temporary modifications include altering its field dimensions to meet FIFA standards of 75-by-115 yards, a requirement that some venues ignored during the 1994 World Cup. The NFL teams retain ownership of the stadium but will operate it without their usual football configuration until after the tournament concludes in July. The stadium's record capacity remains 83,367, established during a Jets-Giants game in October 2023, though this is reduced for World Cup matches to suit soccer specifications. The grass rolls were harvested from ten turf farms across North America starting about 10 months ago, emphasizing the global logistics involved in preparing for the major event.
🏟️ MetLife Stadium converts artificial turf to natural Bermuda grass for 2026 World Cup matches.
⚙️ Installation removed 1,740 seats and used 600 rolls harvested from farms across North America.
⚽ The venue hosts the July 19 final after a slight weather delay pushed back work.
🏟️ Workers have begun installing natural grass at MetLife Stadium in East Rutherford, New Jersey.
⚽ The stadium will host eight matches during the 2026 World Cup, including the final on July 19.
🌱 Bermuda grass is being used for warm-season venues, which includes MetLife Stadium.
🚜 Installation began Wednesday and aims to be completed by late Thursday using about 600 rolls.
🚜 Grass was harvested from 10 turf farms across Canada, Mexico, and the U.S. starting 10 months ago.
⚙️ The foundation layers include sand, Permavoid permeable cloth, ventilation layers, and artificial stitching.
🏈 MetLife Stadium is converting its standard artificial turf to natural grass for this event.
📉 1,740 corner seats were removed from the stadium to accommodate a proper soccer field and runup area.
⚽ FIFA requires a 75-by-115 yard pitch, though some venues ignored this rule during the 1994 tournament.
🚛 Fifteen trucks delivered materials to the site in total over the installation period.
☁️ Installation faced a slight weather delay last night but remains on track according to FIFA officials.
🌎 The expanded 2026 tournament features 48 nations, 104 games across 11 sites in the U.S., Mexico, and Canada.
🇺🇸 Six U.S. venues will utilize Bermuda grass while ten others will use cool-season perennials.
❌ Several star players are expected to be absent due to mounting injuries before kickoff.
Bullish Signals
MetLife Stadium hosts the July 19 World Cup final.
Natural grass installation on schedule despite minor delays.
FIFA confirms strong logistical execution with truck arrivals.
Venue previously held record crowd of 83,367 fans.
Tournament features 104 games across 11 diverse North American sites.
New Jersey lowers train fares to $105 for fans.
Over 320 grass rolls installed using advanced stitching.
Risk Factors
MetLife Stadium capacity reduced from 83,367 for October 2023 games.
FIFA ignored pitch standards in 1994, raising enforcement concerns.
Weather delays threaten artificial turf installation and quality.
Stadium faces high pressure transitioning NFL to World Cup in days.
MetLife Stadium hosts final on July 19 amidst tight deadline.
Bullish Signals
MetLife Stadium is preparing for eight World Cup matches, including the highly anticipated final scheduled for July 19.
Installation of natural grass began on schedule, with a clear goal to complete by late Thursday despite minor weather delays.
FIFA Senior Pitch Manager David Graham confirmed that the work is 'going at plan,' highlighting strong logistical execution with multiple truckloads arriving onsite.
Significant preparations are underway at this major venue, which previously hosted a record 83,367 fans for a Jets-Giants game in October 2023.
FIFA utilized two high-quality grass types tailored to specific climate needs, ensuring optimal playing surfaces across all venues.
The tournament will feature an expanded schedule with 104 games involving 48 nations played at 11 diverse sites across North America.
New Jersey has made travel more accessible for fans by lowering train fares to $105 in response to high demand and outcry.
Over 320 rolls of grass were installed at MetLife, utilizing advanced techniques like artificial stitching to ensure a seamless surface.
Risk Factors
MetLife Stadium, typically home of the NFL's New York Giants and Jets with an artificial turf surface, has had 1,740 seats removed from the corners to accommodate a soccer pitch, reducing its record capacity of 83,367 for sports games set in October 2023.
FIFA required a standard 75-by-115 yard pitch for World Cup games, though this requirement was previously ignored by some venues during the 1994 tournament in the U.S., raising potential questions about compliance or enforcement standards.
Installation of the grass field at MetLife Stadium is scheduled to be completed late Thursday, but it faced a slight weather delay last night, introducing risks of further scheduling disruptions or quality concerns for the artificial stitching process involving 600 rolls.
The stadium is one of eight venues in the U.S. hosting World Cup matches, including the final on July 19, placing significant operational pressure on a facility that must transition from NFL to soccer requirements with only limited time remaining before the June 12 kickoff.
MetLife reported strong Q1 2026 adjusted earnings per share growth of 23%, driven by its 'New Frontier' strategy which delivered balanced performance across all operating segments. Group Benefits performance was particularly robust, aided by favorable life mortality trends among the working-age population, a mild flu season, and high persistency within national accounts. The Asia region saw exceptional earnings growth of 31%, fueled by product innovation in Japan and Korea, including new corporate accident and health products and FX-denominated offerings that contributed to overall regional strength.
The investment management segment showed significant improvement following the integration of PineBridge into MetLife Investment Management (MIM), which pushed segment earnings to $47 million, a 68% increase from $28 million in the prior year. This growth occurred despite a structurally higher expense profile as synergies from the acquisition begin to materialize. The company highlighted its technology investments, totaling $3.2 billion over five years, which contributed to a favorable direct expense ratio of 11.9%, demonstrating the effectiveness of AI-driven efficiency initiatives in managing costs while scaling operations.
Outlook for Q2 suggests non-medical health benefit ratios will moderate as seasonal dental utilization and upfront paid family leave claims normalize, with RIS core spreads expected to remain stable or show modest improvement following the rotation of large Q4 pension risk transfer inflows. The company reaffirmed its free cash flow ratio target between 65% and 75%, supported by a substantial $3.9 billion holding company cash buffer and disciplined capital return plans. Additionally, MetLife executed a strategic divestiture of its Ukraine business to allow the franchise to grow under a new regional parent and opportunistically sold $750 million of private equity assets to manage investment allocations while supporting third-party asset management growth.
Management addressed industry-wide challenges regarding seconded employees in Japan, confirming the practice has been discontinued with no material impact on sales or results. The company also raised $1 billion via a subordinated debt issuance that was oversubscribed more than five times to fund its growth strategy. While acknowledging potential headwinds from COVID-19 pull-forward effects and GLP-1 drug impacts, management emphasized MetLife's ability to bundle life with disability and dental products to protect overall margins and maintain pricing flexibility over the long term.
Earnings surged 23% via 'New Frontier' strategy, with Asia rising 31% and MIM gaining 68%.
Strong investments drove $518m income; AI efficiency cut expenses to an 11.9% direct ratio.
Company exited Ukraine, divested PE assets, and maintained FCF payout targets above 65%.
- 💰 MetLife's Q1 2026 adjusted earnings per share grew by 23%, driven by the 'New Frontier' strategy which delivered balanced performance across all operating segments.
- 🏥 Group Benefits results were strengthened by low life mortality in the working-age population, a light flu season, and high persistency within national accounts.
- 🌏 Earnings in the Asia region increased by 31%, primarily due to new corporate accident and health products and foreign exchange-denominated offerings in Japan and Korea.
- 📊 The integration of PineBridge into MetLife Investment Management (MIM) boosted segment earnings to $47 million, a 68% year-over-year increase despite higher expenses.
- 🤖 AI investments totaling $3.2 billion over five years supported efficiency, resulting in a favorable direct expense ratio of 11.9%.
- 📈 Variable investment income reached $518 million, near the high end of expectations, fueled by strong returns in private equity (2.9%) and venture capital (6.8%).
- 🦷 The non-medical health benefit ratio is expected to moderate in H2 2026 as seasonal dental utilization and paid family leave claims normalize.
- 💼 RIS core spreads should remain stable or improve modestly in Q2 following the rotation of large pension risk transfer inflows from Q4.
- 🛡️ The company maintains its free cash flow payout target of 65%-75%, backed by a $3.9 billion holding company cash buffer and disciplined capital return plans.
- 🚀 MIM earnings are expected to improve throughout 2026 as PineBridge integration synergies are realized and the private asset pipeline converts to commitments.
- 📉 While favorable Group Life mortality trends may eventually impact pricing, management expects this adjustment to occur gradually over years rather than quarters.
- 💸 MetLife divested $750 million of private equity assets at a modest discount to support third-party asset management growth and optimize investment allocations.
- 🇺🇦 The company exited its Ukraine business to allow the franchise to grow under a new regional parent entity.
- 🇯🇵 Management resolved the seconded employee issue in Japan by discontinuing the practice, which has had no material impact on sales or financial results.
- 💹 MetLife issued $1 billion in subordinated debt that was oversubscribed more than five times to provide capital for growth initiatives.
- 📉 Outflows of $2 billion were attributed to expected post-PineBridge close activity and typical early-year client allocation shifts, with stabilization noted by April.
- 🏛️ Despite tight spreads, the company is selective in commercial mortgage loan originations while real estate liquidity and price discovery begin to improve.
- 🔄 The firm is pivoting toward asset-backed financing and other private assets where risk-adjusted returns currently outperform traditional real estate loans.
- 🩺 Management cited potential impacts from GLP-1 drugs on health costs but noted they are still researching specific causalities alongside COVID-19 pull-forward effects.
- 💰 The ability to bundle life, disability, and dental products helps protect MetLife's overall margins against future price adjustments in mortality-sensitive lines.
- ⚠️ Management clarified that the seconded employee issue is an industry-wide matter rather than a company-specific problem affecting business momentum.
Bullish Signals
Adjusted EPS grew 23% driven by New Frontier strategy.
Asia earnings surged 31% via Japan and Korea product innovation.
MIM earnings jumped 68% to $47 million after PineBridge integration.
Technology investments of $3.2 billion achieved an 11.9% expense ratio.
Variable income hit $518 million backed by strong private equity returns.
Holding company cash buffer of $3.9 billion supports free cash flow targets.
MetLife oversubscribed a $1 billion debt issuance five times for growth.
MIM earnings expected to improve throughout 2026 post-PineBridge synergies.
Outflows stabilized with a strong diversified international asset pipeline.
Company divested Ukraine business to focus franchise expansion elsewhere.
Risk Factors
Divested $750M private equity at modest discount signaling hard-to-find growth.
$1B debt issuance may signal underlying liquidity constraints or capital pressure.
$2B outflows suggest investor skepticism over PineBridge acquisition integration.
GLP-1 pricing impacts and drug effects pose future revenue concerns.
Tight spreads limit Commercial Mortgage Loan originations and revenue growth.
Bullish Signals
Adjusted EPS grew 23% year-over-year, driven by the 'New Frontier' strategy with balanced and repeatable performance across all segments.
Asia's earnings surged 31% due to product innovation in Japan and Korea, specifically launching new corporate accident and health products and FX-denominated offerings.
The integration of PineBridge into MetLife Investment Management (MIM) propelled segment earnings to $47 million, a 68% increase from $28 million in the prior year.
Technology investments totaling $3.2 billion over five years contributed to a favorable direct expense ratio of 11.9%, demonstrating strong operational efficiency via AI.
Variable investment income reached $518 million, near the top of the expected range, supported by robust private equity returns of 2.9% and venture capital returns of 6.8%.
The company expects its non-medical health benefit ratio to moderate in H2 2026 as seasonal dental utilization and family leave claims normalize.
MetLife successfully executed a $1 billion subordinated debt issuance that was oversubscribed more than five times, providing ample growth capital.
The $3.9 billion holding company cash buffer supports the company's target of maintaining a 65% to 75% free cash flow ratio.
MIM earnings are projected to improve throughout 2026 as integration synergies from the PineBridge acquisition are realized and the private asset pipeline converts.
Management noted that outflows stabilized in late Q1 and April, with a strong, diversified pipeline emerging across international markets post-PineBridge.
The company divested its business in Ukraine to allow the franchise to grow under a new regional parent, enabling focused expansion elsewhere.
MetLife opportunistically managed investment allocations by divesting $750 million of private equity assets to support third-party asset management growth.
Risk Factors
Management divested $750 million of private equity assets at a modest discount, indicating difficulty finding suitable growth opportunities without taking losses.
The company executed a $1 billion subordinated debt issuance to provide growth capital, which may signal underlying liquidity constraints or capital pressure despite the transaction being oversubscribed.
The company reported $2 billion in outflows attributed to post-closing activity and client allocation shifts, which could indicate investor skepticism regarding the new PineBridge acquisition integration.
Management noted that unfavorable pricing impacts from GLP-1 drugs are still under research but acknowledged COVID-19 pull-forward effects and drug impact as potential drivers for future concerns.
The company is being selective in Commercial Mortgage Loan (CML) originations due to tight spreads, limiting revenue growth in a key lending segment despite improving liquidity conditions.
New Jersey Transit has announced a significant reduction in the round-trip train fare for World Cup matches at MetLife Stadium, dropping the price from $150 to $105. This decision was made effective for matches occurring in June and July 2026, with specific sales beginning on May 13 of that year. NJ Transit CEO Kris Kolluri stated that the agency utilized funds from sponsors and other sources to finance this cost reduction rather than burdening taxpayers or commuters. Governor Mikie Sherrill had previously committed that NJ residents would not bear financial costs for FIFA-related transportation, prompting the search for private funding to achieve a price decrease of at least 30%.
The fare adjustment applies only to World Cup matches, which typically require a valid match ticket for purchase, unlike standard round-trip tickets from Penn Station that usually cost $12.90. A total of eight matches are scheduled at the venue, including the club final on July 19, during which the stadium expects approximately 78,000 attendees per game while NJ Transit plans to sell 40,000 train tickets for each event. In addition to the discounted train fare, general parking at MetLife Stadium will not be available; however, limited parking is offered at the nearby American Dream mall with roughly 5,000 spots listed at $225.
Alternative transportation options include shuttle services and park-and-ride lots to alleviate traffic concerns. Round-trip shuttles from Manhattan locations including two points in Manhattan and one at the Port Authority Bus Terminal cost $80, while an eastern park-and-ride located at the Hackensack Meridian School of Medicine offers space for 2,500 vehicles for the same price with drop-offs at designated MetLife parking lots. These logistical details aim to manage the influx of fans attending the tournament while adhering to the financial constraints set by state leadership.
🚄 World Cup train fares drop from $150 to $105 for eight matches.
💰 Funding comes from sponsors and revenue, not taxpayer money.
🅿️ General parking is gone; alternatives include Mall spots at $225 or shuttles for $80.
🚄 NJ Transit has announced a reduction of the round-trip train fare for World Cup matches at MetLife Stadium from $150 to $105.
💰 The price cut was funded entirely by sponsorships and other revenue sources rather than public funds.
🤝 NJ Transit CEO Kris Kolluri confirmed that Governor Mikie Sherrill requested that no financial burden be placed on New Jersey taxpayers or commuters for FIFA-related costs.
📉 Compared to a standard non-event round-trip fare of $12.90, the discounted World Cup price represents an approximately 30% reduction from the original $150 estimate.
🗓️ Eight matches scheduled for June and July at MetLife Stadium will offer this discounted rate on trains.
⚽ Train sales begin on May 13, but passengers must already possess a valid World Cup match ticket to purchase transportation.
🚧 General parking is unavailable at MetLife Stadium for the tournament.
🅿️ Limited parking options are available at the nearby American Dream mall, which offers about 5,000 spots for $225 on the official website.
🚌 Shuttle services will be offered from Manhattan locations and a New Jersey park-and-ride lot for $80 per round-trip pass.
📦 NJ Transit plans to sell up to 40,000 train tickets for each match despite an expected attendance of around 78,000 fans.
Bullish Signals
NJ Transit secured sponsorships to subsidize World Cup train travel.
Round-trip fares dropped over 30% from $150 to $105.
NJ Transit sells only 40k tickets vs 78k expected demand.
General parking at MetLife Stadium is entirely unavailable.
American Dream mall parking limited to 5,000 spots at $225.
Shuttles add $80 fees on top of existing ticket prices.
Bullish Signals
NJ Transit has successfully secured sponsorships and funding from other sources to subsidize the cost of World Cup train travel, allowing for a significant price reduction.
The round-trip fare for fans attending World Cup matches at MetLife Stadium has been lowered by over 30%, dropping from $150 to just $105 per ticket.
New Jersey Governor Mikie Sherrill's commitment to avoiding financial burdens on taxpayers and commuters was honored, ensuring private funding covered these event costs.
NJ Transit plans to sell 40,000 train tickets for each of the eight upcoming matches in June and July to meet high demand from the expected 78,000 fans per game.
Affordable shuttle services are available for $80 round-trip from various Manhattan locations and a park-and-ride site, providing accessible options for attendees arriving by car or bus.
Risk Factors
NJ Transit will sell only 40,000 train tickets for each match despite the venue expecting 78,000 fans per match, creating a significant shortage of official transportation options.
General parking at MetLife Stadium is entirely unavailable for World Cup matches, forcing fans to rely on limited alternative arrangements nearby.
Parking at the nearby American Dream mall is restricted to approximately 5,000 spots and is priced high at $225, limiting accessibility for many attendees.
Shuttle services from key locations like Manhattan and Grand Central cost an additional $80 on top of ticket prices, increasing total travel costs significantly compared to the reduced train fare.
MetLife Inc. (MET) reported first-quarter 2026 results that surpassed analyst expectations across earnings and revenue metrics. Adjusted operating earnings per share reached $2.42, a 7.6% beat against the Zacks Consensus Estimate and representing a 23% year-over-year increase. Operating revenues climbed 4.5% to $19.7 billion, driven by strong investment income of $5.5 billion (up 5%) and solid business volume growth across segments. Group Benefits led performance with earnings up 19%, while International Retirement Solutions (RIS) saw significant PFO growth of 58%, supported by a robust Asian market recovery where earnings jumped 31%.
Despite overall success, higher expenses due to policyholder benefits caused the expense ratio to widen to 20.3%, and specific units faced headwinds. The Corporate & Other unit posted an adjusted loss of $177 million, wider than the prior year's $129 million loss, which offset some gains. Latin America reported earnings that declined 9% on a constant-currency basis due to unfavorable tax-related items, though total PFOs grew 25% on a reported basis. Nevertheless, core business metrics remained resilient with adjusted PFOs of $13.3 billion globally, up 10%.
Looking ahead, MetLife raised its outlook for variable investment income to approximately $1.6 billion for the year and guided Group Benefits PFO growth at 4-7% annually. The company reiterated a target return on equity range of 15-17% and expects double-digit adjusted EPS growth in the near term. Financial position remained strong with cash and equivalents at $22.7 billion, though book value per share fell slightly to $37.92 from the prior year-end figure following share buybacks and dividends.
📈 MetLife EPS beat estimates by 7.6%, rising 23% year over year to $2.42.
⚠️ Gains faced headwinds from higher expenses, Latin American tax issues, and a wider corporate loss.
💵 Cash reserves rose to $22.7 billion while equity decreased slightly to $27.6 billion.
🔄 The company executed $750 million in buybacks and paid $350 million in dividends.
📈 MetLife reported first-quarter 2026 adjusted operating EPS of $2.42, beating analyst estimates by 7.6% and growing 23% year over year.
💰 Adjusted operating revenues increased 4.5% to $19.7 billion, surpassing the consensus mark by 2.4%.
📉 Strong performance was driven by improved net investment income, favorable underwriting, and solid business volume growth across segments.
⚠️ Upside was partially offset by higher expenses, unfavorable tax items in Latin America, and a wider-than-expected loss in the Corporate & Other unit.
💵 Adjusted PFOs reached $13.3 billion, rising 10% year over year when excluding pension risk transfer transactions.
📊 Net investment income grew 5% to $5.5 billion due to asset growth and improved variable investment performance.
🏥 Group Benefits posted adjusted earnings of $439 million, a 19% increase driven by better underwriting and volume growth.
🌏 International segments including RIS, Asia, Latin America, and EMEA all reported double-digit or strong single-digit earnings growth.
💼 MetLife Investment Management saw adjusted earnings surge 68%, though it missed the consensus estimate by 9.2%.
⚠️ Corporate & Other unit incurred an adjusted loss of $177 million, which was wider than the prior year's $129 million loss.
💰 Total expenses rose 2% to $17.6 billion due to increased policyholder benefits and claims costs.
📉 The adjusted expense ratio deteriorated 30 basis points to 20.3%, excluding notable items and PRT adjustments.
⚖️ Net income climbed 29.7% to $1.1 billion, while adjusted return on equity improved to 17%.
💵 Cash and cash equivalents stood at $22.7 billion, up from $22 billion at the end of 2025.
📉 Total assets remained relatively stable at $743.2 billion compared to $745.2 billion at the end of 2025.
💳 Long-term debt decreased slightly to $14.4 billion, while equity totalled $27.6 billion down from $28.7 billion.
🔄 Share buybacks amounted to $750 million in Q1 and approximately $200 million in April 2026.
💸 Dividends paid included $350 million for the quarter under review, with book value per share up 7.8% to $37.92.
MetLife reported first-quarter adjusted EPS of $2.42, beating the Zacks Consensus Estimate by 7.6% with a full-year bottom line advance of 23%.
Adjusted operating revenues improved 4.5% year over year to $19.7 billion, surpassing consensus expectations by 2.4%.
Net investment income grew 5% year over year to $5.5 billion driven by asset growth and improved variable income.
Group Benefits segment earnings rose 19% year-over-year to $439 million, exceeding analyst estimates by 22.5% on strong underwriting results.
RIS unit adjusted earnings advanced 11% year-over-year to $451 million with a significant 58% increase in Adjusted PFOs excluding pension risk transfers.
Asia segment saw adjusted earnings surge 31% year-over-year to $487 million, supported by volume growth and improved investment income.
Latin America delivered strong reported Adjusted PFO growth of 25% year-over-year to $1.9 billion driven by solid business growth and persistency.
EMEA segment recorded a robust 33% year-over-year earnings advance to $110 million fueled by strong volumes and policy renewals.
MetLife Investment Management experienced impressive 68% year-over-year earnings growth to $47 million on back of strong business expansion.
Company cash position strengthened with $22.7 billion in cash and equivalents, up from $22 billion at the end of 2025.
Book value per share increased 7.8% year-over-year to $37.92 as of March 31, 2026.
Management demonstrated confidence with an expectation of double-digit adjusted EPS growth in the near term.
Risk Factors
Higher expenses and unfavorable tax-related items in Latin America partially offset earnings growth.
The loss in the Corporate & Other unit widened to $177 million from $129 million in the prior year quarter.
MetLife's Metlife Investment Management segment missed its Zacks Consensus Estimate by 9.2%.
Total assets declined year over year, dropping from $745.2 billion at the end of 2025 to $743.2 billion as of March 31, 2026.
Total equity contracted from $28.7 billion to $27.6 billion despite share buybacks and dividend payments.
MetLife has raised the expense ratio forecast to 12.1%, indicating potential cost pressures ahead.
Management maintains expectations for a pre-tax variable investment income of around $1.6 billion for 2026, which is below the growth trajectory implied by prior years' results.
MetLife (MET) reported first-quarter earnings that surpassed Wall Street consensus estimates, driven primarily by a 10% increase in net investment income and strong performance within its group benefits segment. The company achieved an adjusted earnings per share of $2.42, exceeding the average analyst expectation of $2.27, which represents a significant improvement over the $1.96 reported for the same quarter last year. This financial result highlights a dual-engine growth strategy where robust investment returns complemented by favorable life underwriting results and volume growth in its group benefits unit successfully lifted overall profitability.
The report specifically notes that the surge in investment income was a key catalyst for beating expectations, suggesting that MetLife's asset management strategies or investment portfolio performance during this period outpaced the broader market or previous quarters. Additionally, the strong showing in the group benefits segment indicates successful expansion or retention within that specific line of business, contributing positively to both underwriting margins and overall revenue streams. These results collectively suggest that MetLife is navigating its current economic environment with diversified growth drivers across investments and core insurance operations.
📈 MetLife Q1 adjusted EPS of $2.42 beat Wall Street estimates.
💰 Net investment income rose 10% year-over-year to drive earnings growth.
👥 Group benefits results strengthened via favorable underwriting and volume gains.
📊 Strong quarterly performance significantly improved upon the previous $1.96 EPS.
MetLife's Q1 adjusted earnings per share came in at $2.42, exceeding the Wall Street consensus estimate of $2.27. 📈
The company reported a 10% year-over-year growth in net investment income as a primary driver of the quarterly beat. 💰
Group benefits results contributed positively, with favorable life underwriting performance and volume growth highlighted. 👥
Previous Q1 EPS of $1.96 serves as a comparison point for the current quarter's improved financial performance. 📊
The report was published on May 6, 2026, by Seeking Alpha author Liz Kiesche. 📅
Bullish Signals
MetLife Q1 EPS reached $2.42, beating estimates.
Net investment income grew 10% to boost profits.
Group benefits saw favorable underwriting and volume growth.
Risk Factors
Sustainable earnings growth relies heavily on non-operable investment income.
Report omits critical revenue growth and expense control metrics.
Bullish Signals
MetLife reported Q1 adjusted earnings per share (EPS) of $2.42, surpassing the average analyst estimate of $2.27 and representing a significant increase from $1.96 in the prior year.
Net investment income grew by 10% during the quarter, providing a substantial tailwind to overall profitability.
The group benefits segment delivered favorable life underwriting results alongside volume growth, contributing positively to the quarter's performance.
Risk Factors
The earnings beat was primarily driven by investment income growth rather than organic business improvements, which may not be sustainable in the current interest rate environment.
The Q1 adjusted EPS of $2.42 barely represents a 23% increase from $1.96 last year, suggesting underlying core operational growth might be limited.
Despite beating estimates, the article focuses almost exclusively on top-line drivers like investment income, leaving out any mention of revenue growth or expense control in the first quarter.
MetLife (NYSE:MET) reported first-quarter fiscal year 2026 financial results that partially missed market expectations. The company posted revenue of $19.07 billion, representing a modest 1.3% year-over-year increase but falling short of the analyst estimate of $19.41 billion. While net premiums earned came in at $12.12 billion, exceeding the consensus of $11.65 billion by about 4%, and non-GAAP profit per share hit $2.42 against an expected $2.27, the report highlighted a significant miss in book value per share. This metric declined by 35% to $37.92, compared to analyst projections of $58.37, reflecting concerns about long-term capital growth relative to liability structures.
The article provides historical context regarding MetLife's revenue trajectory, noting that the company has grown at an annualized rate of 3.2% over the last five years, which is described as sluggish relative to sector benchmarks. However, it highlights a more encouraging trend of 4.4% annualized growth over the last two years. The report emphasizes that net premiums earned constitute roughly 69% of MetLife's revenue, making it the most reliable and consistent source of income compared to investment fees or variable investment returns. Analysts note that while the stock traded flat at $80.22 following the earnings release, management views the current quarter as a single data point within a longer-term quality assessment framework.
Beyond the immediate financial figures, the piece delves into the mechanics of insurance companies as balance sheet businesses where float—the premiums collected before claims are paid—is invested to generate investment income alongside premium revenue. The analysis suggests that Book Value Per Share (BVPS) is a critical metric for evaluating insurers because it captures the residual value of shareholders after accounting for both assets and liabilities, offering a view on long-term capital growth that is harder to manipulate than EPS. Despite the mixed quarter with missed revenue and book value targets, the analysts conclude that earnings performance should be evaluated in conjunction with valuation metrics to determine if MetLife represents a buy opportunity now, directing interested readers to their full research report for deeper actionable insights.
📉 Revenue rose 1.3% to $19.07B, missing analyst estimates of $19.41B.
💰 Adjusted EPS hit $2.42, beating expectations by 6.6% despite missed revenue.
📉 Book value per share dropped 7.1% YoY to $37.92.
📈 Short-term revenue growth improved to 4.4% annually over the last two years.
⚠️ Stock remained flat due to mixed results and lower-than-expected book value.
📉 MetLife's Q1 CY2026 revenue grew 1.3% year-over-year to $19.07 billion, missing analyst estimates of $19.41 billion.
📊 Net premiums earned increased to $12.12 billion, beating expectations due to a lower-than-expected decline in core insurance business volume.
💰 Adjusted earnings per share reached $2.42, surpassing the consensus estimate of $2.27 by 6.6%.
🔻 Book value per share declined 7.1% year-over-year to $37.92, significantly below analyst estimates of $58.37.
💵 The company reported a pre-tax profit margin of 7.9% with total pre-tax profits of $1.51 billion.
🏢 MetLife continues to derive 69.1% of its revenue from core insurance underwriting over the last five years.
📈 Short-term growth has improved, with annualized revenue growth at 4.4% over the last two years compared to a sluggish 3.2% five-year average.
⚠️ The stock remained flat at $80.22 immediately following earnings due to mixed results on book value and revenue metrics.
🕰️ Founded in 1863, this New York-based financial services firm provides insurance, annuities, and asset management globally.
📉 Over the last five years, book value per share declined at a rate of 12.7% annually on a long-term basis.
🚀 Analysts project a massive 70.3% growth in book value per share over the next 12 months to reach $58.37.
📝 Management noted that certain quarters are outliers due to investment gains/losses and do not reflect recurring fundamentals.
🛑 The overall quarter was considered "softer" by analysts because revenue missed targets despite strong earnings per share performance.
🔍 Investors should evaluate MetLife in the context of longer-term business quality alongside current valuation metrics.
Bullish Signals
MetLife profit beat estimates by 6.6% at $2.42/share.
Net premiums hit $12.12B, exceeding forecasts by 4%.
Revenue growth accelerated to 4.4%, above long-term trends.
Book Value projected to grow 70.3% in 12 months.
Risk Factors
Revenue of $19.07B missed estimates by 1.7%.
Net premiums fell 4% year-over-year to $12.12B.
Book value per share dropped 35% vs. estimates.
Five-year revenue growth of 3.2% lags sector.
BVPS missed despite EPS and premium beats.
Bullish Signals
MetLife reported non-GAAP profit of $2.42 per share, which significantly beat analysts' consensus estimates by 6.6%.
Net premiums earned reached $12.12 billion, exceeding analyst estimates of $11.65 billion, driven by a resilient 4% year-on-year beat.
MetLife's two-year annualized revenue growth accelerated to 4.4%, which is above its five-year trend and shows recent improvement.
Over the next 12 months, consensus estimates project MetLife's Book Value per Share to grow by an elite 70.3% to $58.37.
MetLife's global financial services business has maintained a long history of providing insurance, annuities, and asset management since its founding in 1863.
Risk Factors
MetLife's Q1 CY2026 revenue of $19.07 billion missed Wall Street estimates by 1.7%, despite year-over-year growth only reaching a sluggish 1.3%.
Net premiums earned, which historically make up 69.1% of total revenue and serve as the most reliable metric for insurers, declined 4% year over year to $12.12 billion versus analyst expectations.
Book value per share dropped significantly by 35% compared to analyst estimates ($37.92 vs $58.37), indicating potential capital deterioration or valuation compression.
MetLife's five-year annualized revenue growth of 3.2% is described as sluggish and falls below the sector benchmark, raising concerns about its long-term growth baseline.
The company missed analyst consensus estimates for the key metric of Book Value per Share (BVPS), even though it beat estimates on EPS and Net Premiums Earned.
Despite beating profit estimates, the overall quarter was characterized as 'softer' due to the miss in top-line revenue and significant underperformance in BVPS relative to projections.
MetLife reported Q1 CY2026 earnings with mixed results relative to analyst expectations, driven primarily by a miss in revenue and book value per share despite a profit beat. The company's non-GAAP profit of $2.42 per share exceeded the consensus estimate of $2.27, representing a 6.6% upside. However, total revenue came in at $19.07 billion, falling short of the estimated $19.41 billion and growing only 1.3% year over year compared to analyst forecasts. Net premiums earned totaled $12.12 billion, slightly beating estimates at $11.65 billion, yet this segment saw a 6.4% year-over-year decline. Consequently, the stock price remained flat at $80.22 immediately following the announcement.
Key financial metrics highlighted significant divergence between earnings and balance sheet performance. Pre-tax profit stood at $1.51 billion with a 7.9% margin, while book value per share dropped to $37.92, missing analyst estimates of $58.37 by 35% and marking a 7.1% year-over-year decline. Management noted that quarters not explicitly detailed in the report were outliers affected by outsized investment gains or losses, which can distort recurring fundamentals. The company's five-year compounded annual revenue growth rate has been sluggish at 3.2%, though performance improved to 4.4% annually over the last two years.
Analyst commentary emphasizes that while earnings per share and premiums earned are crucial for gauging business health, book value per share is a critical indicator of long-term capital growth that is harder to manipulate than EPS. The report notes that Net Premiums Earned accounted for 69.1% of total revenue over the last five years, establishing it as the primary revenue driver. Looking ahead, consensus estimates project a substantial 70.3% increase in book value per share to $58.37 over the next 12 months. However, the company's historical trajectory shows a 12.7% annual decline in book value over the last five years, with a slower 2.5% annual drop over the most recent two-year period before the current reported figures. The overall assessment characterizes the quarter as weaker due to the revenue miss and significant underperformance in book value relative to expectations.
📉 Revenue rose 1.3% but fell short of analyst estimates by 1.7%.
💰 Non-GAAP profit per share beat consensus, though book value missed significantly.
📊 Insurance premiums drive 69.1% of revenue despite a recent annual decline.
📉 MetLife's Q1 CY2026 revenue came in at $19.07 billion, representing a 1.3% year-over-year increase but missing Wall Street estimates by 1.7%.
💰 Non-GAAP profit per share reached $2.42, surpassing analyst consensus estimates by 6.6%.
📜 Net Premiums Earned totaled $12.12 billion, beating expectations with a 4% positive variance despite a year-on-year decline of 6.4%.
💵 Pre-tax profit for the quarter was $1.51 billion, maintaining a pre-tax margin of 7.9%.
📉 Book Value Per Share (BVPS) declined 35% from consensus estimates at $37.92 versus an expected $58.37.
🏛️ Founded in 1868, MetLife is a global financial services company offering insurance, annuities, benefits, and asset management services.
💵 Over the last five years, the company experienced sluggish revenue growth with a compounded annual rate of 3.2%.
📈 Recent two-year annualized revenue growth improved to 4.4%, indicating a stronger recent trend compared to the long-term average.
🎯 Net premiums earned account for 69.1% of total revenue, identifying insurance operations as the primary business driver.
⚠️ The stock remained flat at $80.22 immediately after the earnings report due to mixed results on key metrics.
📊 Book value reflects long-term capital growth and is considered a crucial metric for assessing insurer business quality.
📉 BVPS has seen an annual decline of 12.7% over the past five years, though the recent two-year pace slowed to 2.5%.
🔮 Consensus estimates project a potential 70.3% growth in BVPS over the next 12 months to reach $58.37.
🤖 Analysts view investment and fee income as more volatile than core insurance operations, focusing heavily on premium growth.
⚠️ The quarter was characterized as weaker overall because revenue and book value missed targets despite EPS beats.
Bullish Signals
MetLife non-GAAP profit of $2.42 beat estimates by 6.6%.
Adjusted EPS reached $2.42, surpassing analyst expectations of $2.27.
Net premiums earned of $12.12B exceeded the analyst estimate.
MetLife's annualized revenue growth accelerated to 4.4% recently.
Consensus projects MetLife BVPS to grow 70.3% to $58.37.
Risk Factors
Revenue missed estimates by $0.34B with only 1.3% YoY growth.
BVPS significantly missed expectations at $37.92 versus $58.37 target.
Core insurance Net Premiums Earned declined 4% year-on-year.
Five-year revenue growth of 3.2% trailed industry benchmarks.
BVPS eroded 12.7% annually over the last five years.
Bullish Signals
MetLife's non-GAAP profit of $2.42 per share beat analysts' consensus estimates by 6.6%.
Adjusted EPS reached $2.42, surpassing analyst expectations of $2.27.
Net premiums earned of $12.12 billion exceeded the analyst estimate of $11.65 billion.
MetLife's annualized revenue growth accelerated to 4.4% over the last two years, which is above its five-year trend.
Consensus estimates project MetLife's Book Value per Share (BVPS) to grow by an elite 70.3% over the next 12 months to $58.37.
MetLife provides insurance, annuities, employee benefits, and asset management services to a global client base.
Risk Factors
MetLife's revenue fell short of Wall Street estimates at $19.07 billion, missing the consensus by $0.34 billion and growing only 1.3% year-over-year.
Book Value Per Share (BVPS) suffered a significant miss against analyst expectations of $58.37, closing at $37.92 due to a 7.1% decline year-over-year that significantly trailed the projected growth.
The core insurance business is lagging with Net Premiums Earned declining 4% year-on-year, raising concerns about the company's ability to grow its primary revenue stream.
Over the past five years, MetLife's compounded annual revenue growth rate was merely 3.2%, which fell short of the broader insurance sector benchmark.
The company's long-term BVPS has eroded at a 12.7% annual clip over the last five years, indicating persistent challenges in capital growth despite recent recovery.
The article provides an analysis of Wall Street analyst estimates for MetLife (MET) ahead of its quarterly earnings report, projecting EPS of $2.23 per share, a 13.8% year-over-year increase, and revenues of $19.2 billion, representing a 2% rise from the prior quarter. Recent data indicates that the consensus EPS estimate has been revised downward by 1.2% over the past 30 days, highlighting the dynamic nature of analyst projections which are often correlated with short-term stock price movements. Beyond aggregate figures, detailed breakdowns reveal that revenue premiums are estimated at $11.49 billion (down -2%), while other revenues are projected at $705.48 million (+2.7%). Key segment estimates show significant growth in net investment income at $5.68 billion (+16.3%) and a substantial increase of 1,425.8% in adjusted corporate revenue. Regional analysis predicts Latin America total adjusted revenue of $2.17 billion (+13.2%), Asia reaching $3.14 billion (+8.9%), and EMEA at $807.11 million (+11.2%).
MetLife's stock has performed strongly, with shares gaining 13.3% over the past month compared to the Zacks S&P 500 composite's 10.5% gain, though it currently carries a Zacks Rank #3 (Hold), suggesting an expectation to mirror overall market performance in the near future. The analysis emphasizes that while consensus estimates for EPS and total revenue provide a baseline, examining specific line items such as universal life fees ($1.29 billion) and segmented investment incomes offers deeper insight into business health. For instance, Latin America net investment income is forecast at $456.73 million (+12.2%), Asia net investment income at $1.41 billion (+16.8%), and EMEA net investment income at $66.84 million (+15.2%). Other revenue streams also show growth, with Asia other revenues estimated at $19.43 million (+29.5%) and universal life fees showing a 5.2% increase year-over-year.
Notably, the provided text includes a segment on Uber Technologies (UBER) after the MetLife analysis, forecasting Uber's quarterly earnings at $0.71 per share, which represents a 14.5% year-over-year decline, and revenues of $13.27 billion, a 15% increase. Similar to the MetLife section, this part notes a 1% downward revision in Uber's consensus EPS over the last 30 days. Metric breakdowns for Uber indicate mobility revenue of $6.99 billion (+7.6%), freight revenue of $1.27 billion (+0.8%), and delivery revenue of $4.92 billion (+30.2%). Geographic estimates for Uber show Latin America revenue at $873.65 million (+21.9%) and United States and Canada revenue reaching $6.87 billion (+10.4%), with the analysis noting that the Asia Pacific revenue figure was cut off in the source text.
📈 Analysts project MetLife quarterly EPS of $2.23, a 13.8% year-over-year increase.
💰 Revenue estimates total $19.2 billion, though 'Revenue-Premiums' are expected to drop 2%.
🌍 Net investment income across all regions is forecast to surge significantly year-over-year.
🚀 Shares rose 13.3% last month, outperforming the S&P 500 despite a Hold rating.
🏢 Wall Street analysts project MetLife (MET) quarterly earnings at $2.23 per share, representing a 13.8% year-over-year increase.
💰 Consensus revenue estimates for MetLife stand at $19.2 billion, reflecting a 2% growth compared to the prior-year quarter.
📉 The consensus EPS estimate has been revised downward by 1.2% over the past 30 days as analysts reassess forecasts.
📈 Analysts expect MetLife's 'Revenue-Premiums' to reach $11.49 billion, marking a 2% decline from the year-ago quarter.
💵 'Revenue-Other Revenues' are projected at $705.48 million, indicating a 2.7% year-over-year increase.
💼 Policy fees related to universal life and investment-type products are estimated at $1.29 billion, up 5.2% year-over-year.
🌍 Net investment income is forecasted to hit $5.68 billion, driven by a strong 16.3% year-over-year increase.
📜 Adjusted Revenue for Latin America is expected to reach $2.17 billion, showing a 13.2% year-over-year gain.
🏢 Corporate & other net investment income is predicted at $1.08 billion, representing a massive 1425.8% increase from the prior quarter.
🌍 EMEA adjusted revenue totals are projected at $807.11 million, up 11.2% year-over-year.
🌏 Asia total adjusted revenue is estimated at $3.14 billion, reflecting an 8.9% year-over-year increase.
💰 Asia net investment income specifically is forecasted at $1.41 billion, a 16.8% rise from the prior-year quarter.
🌍 EMEA net investment income is expected to reach $66.84 million, up 15.2% year-over-year.
💵 Latin America net investment income is projected at $456.73 million, indicating a 12.2% year-over-year increase.
🚀 MetLife shares have gained 13.3% over the past month, outperforming the S&P 500 composite's 10.5% gain.
📊 MET currently holds a Zacks Rank #3 (Hold), suggesting it may mirror overall market performance in the near term.
Bullish Signals
MetLife analysts project quarterly earnings of $2.23 per share, representing an impressive 13.8% year-over-year increase.
Revenue is expected to reach $19.2 billion, marking a 2% growth from the same quarter last year.
'Net investment income' is forecasted to surge by 16.3% year over year to $5.68 billion.
'Adjusted Revenue- Asia- Net investment income' shows robust growth with a projected increase of +16.8% year over year.
'Total Adjusted Revenue- Latin America' is estimated to grow by +13.2%, reaching $2.17 billion.
'Adjusted Revenue- Corporate & other- Net investment income' displays exceptional momentum with a year-over-year change of +1425.8%.
MetLife shares have delivered +13.3% returns over the past month, outperforming the S&P 500 composite's +10.5% gain.
Multiple revenue segments demonstrate strong double-digit growth, including 'Revenue- Universal life and investment-type product policy fees' at +5.2%.
Risk Factors
Wall Street analysts have collectively revised their EPS consensus estimates downward by 1.2% for MetLife (MET) over the past 30 days, signaling a bearish reassessment of the company's earnings potential before its quarterly report.
Analysts project that 'Revenue- Premiums' will decline by 2% year-over-year to $11.49 billion, indicating weakness in one of the key revenue streams for MetLife.
MetLife's stock is currently assigned a Zacks Rank #3 (Hold), suggesting analysts do not see strong near-term upside and expect the stock to merely mirror overall market performance rather than outperform.
The significant 495% year-over-year increase in 'Adjusted Revenue- Corporate & other- Net investment income' ($1.08 billion) may mask underlying operational struggles or one-off items that could inflate current earnings estimates without reflecting sustainable growth.
Sun Life Financial Inc. has reached a settlement in principle to resolve a long-running class action lawsuit regarding individual life insurance policies sold by Metropolitan Life Insurance Company (MetLife) during the 1980s and 1990s. The proposed agreement would see Sun Life provide up to $213.5 million in settlement value to eligible policyholders, pending final court approval. Upon approval, Sun Life expects to record an estimated after-tax charge of approximately $145 million against its first quarter of 2026 reported net income. This matter relates specifically to the interpretation of policy language in historic MetLife life insurance policies that Sun Life inherited through past Canadian acquisitions, a legal issue explicitly stated by the company as not involving any policies sold under its own brand.
The class action litigation has been ongoing for years and was recently disclosed in Note 22G of Sun Life's 2025 Annual Consolidated Financial Statements. Under the terms of a previous indemnity arrangement where MetLife provided coverage for these legacy policies, Sun Life plans to seek full recourse from MetLife for the settlement costs should the deal receive court approval. If approved, the agreement would bring finality to this long-standing dispute and provide certainty for affected policyholders. As of December 31, 2025, Sun Life reported assets under management totaling $1.60 trillion across operations in Canada, the United States, Europe, and Asia-Pacific, with shares traded on the Toronto, New York, and Philippine stock exchanges. The settlement process and subsequent notice to class members remain subject to judicial approval before becoming effective.
🏦 Sun Life settles historic MetLife policy lawsuits in principle.
💰 Up to $213.5 million will be paid to eligible claimants.
📉 An estimated $145M after-tax charge impacts Q1 2026 income.
⚖️ Costs target legacy acquisitions, not current Sun Life products.
🔄 Full recourse sought from MetLife for settlement expenses.
🏦 Sun Life has reached a settlement in principle to resolve a class action lawsuit regarding historic MetLife life insurance policies sold in the 1980s and 1990s.
💰 The proposed deal involves providing up to $213.5 million in settlement value to eligible policyholders, subject to final court approval.
📉 Sun Life expects to record an estimated after-tax charge of approximately $145 million against its Q1 2026 reported net income.
⚖️ The litigation concerns the interpretation of legacy policy language inherited through past Canadian acquisitions rather than current Sun Life products.
🔍 This matter was previously disclosed in Note 22G of Sun Life's 2025 Annual Consolidated Financial Statements.
🔄 MetLife provided an indemnity for these legacy policies, and Sun Life plans to seek full recourse from MetLife to recover settlement costs if approved.
✅ Finalizing the agreement will bring closure to a long-standing legal dispute and provide certainty for affected policyholders.
🕊️ The settlement process remains pending court approval before any payments are made or charges recorded.
Bullish Signals
Sun Life has reached a settlement in principle that will provide up to $213.5 million in settlement value to eligible policyholders, subject to court approval.
MetLife is providing an indemnity relating to these legacy policies, allowing Sun Life to seek full recourse and effectively attempt to recover the settlement costs.
The agreement would bring finality to a long-standing legal dispute, providing certainty for affected policyholders.
Sun Life inherited these historic MetLife policies through past Canadian acquisitions, but the company emphasized that the matter does not involve any policies or products it has sold under its own brand.
Risk Factors
Sun Life expects to record an estimated after-tax charge of approximately $145 million to its Q1 2026 reported net income, which will negatively impact earnings.
The company must provide up to $213.5 million in settlement value to eligible policyholders if the court approves the deal, representing a significant cash outflow.
If the settlement is approved by the court, Sun Life only plans to seek full recourse from MetLife under the indemnity arrangement, implying potential risk of insufficient recovery.
The litigation concerns historic MetLife policies sold in the 1980s and 1990s that Sun Life inherited, suggesting long-tail liability risks associated with legacy acquisitions.
The proposed settlement remains subject to court approval, creating uncertainty regarding the timing and finality of this significant financial event.
The provided text appears to be a webpage scrape or raw HTML dump from Moneycontrol.com rather than a news article with a coherent narrative about "met." The content includes navigational elements, advertisements for stocks like Adani Power and Ola Electric, cryptocurrency promotion banners, insurance company lists, and website verification messages. While it mentions specific NAV (Net Asset Value) data for the "PNB MetLife - Met Smart Plus Accelerator" plan—citing Rs 80.6507 as of April 29, 2025, and a projected or different figure of Rs 80.9686 for April 29, 2026—it does not offer a descriptive summary, analysis, or news story regarding the plan's performance, strategy, or implications beyond these raw data points. The text functions primarily as an interface listing for an equity-linked insurance product rather than a financial news report. Consequently, a meaningful summary of news content cannot be constructed from this source material.
SKIP
📈 NAV projected to rise from Rs 80.65 to Rs 80.97 by April 2026.
📉 Fund operates under PNB MetLife with historical data tracing back to 2000.
⚠ Moneymoney warns against scams promising assured returns and demands official verification.
📈 The Net Asset Value (NAV) of PNB MetLife's Met Smart Plus Accelerator fund was recorded at Rs 80.6507 as of April 29, 2025.
📉 The projected NAV for the same fund is estimated to reach Rs 80.9686 by April 29, 2026.
💼 PNB MetLife operates this accelerator fund under its Life Insurance subsidiary, offering a product within the mutual fund or unit-linked insurance sector.
📊 The platform provides tools for users to calculate returns and analyze performance data over historical time periods ranging from 2000 to 2026.
⚠️ Moneycontrol issued a specific warning against individuals falsely claiming affiliation to solicit funds with promises of assured returns.
🔒 Users are advised to verify their accounts through official channels if approached by such unauthorized representatives for investment purposes.
📌 The article page also lists other top Indian stocks and insurance companies as related financial instruments but does not provide detailed analysis on them.
💻 A copyright notice confirms that all content belongs to Network18 Media & Investments Limited and reproduction is prohibited without permission.
Bullish Signals
PNB MetLife Smart Plus NAV grew from Rs 80.65 to Rs 80.97.
Backed by powerful trader and investor packs for diverse needs.
Risk Factors
NAV grew marginally from Rs 80.65 to 80.97.
0.4% annualized return barely justifies high expense ratio.
The PNB MetLife - Met Smart Plus Accelerator unit has demonstrated positive NAV growth, increasing from Rs 80.6507 as on 29-Apr-2025 to Rs 80.9686 as on 29-Apr-2026.
The product is backed by a powerful mix of both trader and investor packs, designed to cater to diverse investment needs through timely expert advice.
Risk Factors
The fund's Net Asset Value (NAV) has grown only marginally from Rs 80.6507 in April 2025 to Rs 80.9686 by April 2026, indicating very poor performance over the one-year period.
An annualized return of approximately 0.4% suggests the fund is generating returns barely above or below the risk-free rate, failing to justify its expense ratio.
The product description emphasizes 'trader and investor packs' for 'volatile markets', which introduces significant downside risk for conservative investors seeking stability.
MetLife announced on Tuesday that its board of directors approved an increase to the company's quarterly common stock dividend by 4.4%, raising the payout from 56.75 cents to 59.25 cents per share. This adjustment brings the equivalent annualized dividend to $2.37 per share, based on the company's latest closing stock price of $78.28. Consequently, the new dividend yield is calculated at 3%.
This move continues MetLife's long-term trend of consistent growth in shareholder returns, as the insurance giant has raised its common stock quarterly dividend at a compound annual growth rate of 8.1% since 2011. The updated dividend is scheduled to be payable on June 9 to shareholders who are recorded on May 12.
The information was published by MarketWire via Dow Jones Newswires on April 28, 2026, noting that the data provided reflects U.S. stock quotes through Nasdaq with intraday data delayed by at least 15 minutes or according to exchange requirements.
📈 MetLife raises quarterly dividend 4.4% to 59.25 cents.
💰 Annualized rate reaches $2.37 with a ~3% yield.
📉 Dividend grew 8.1% annually since 2011.
📅 Record date is May 12 for June 9 payment.
📈 MetLife increased its quarterly dividend by 4.4% to 59.25 cents per share.
💰 This adjustment raises the company's annualized dividend rate to $2.37 per share.
📊 The current yield stands at approximately 3% based on the latest closing stock price of $78.28.
📉 MetLife has grown its quarterly dividend by a compound annual growth rate of 8.1% since 2011.
📅 Shareholders must be on record by May 12 to receive the payment scheduled for June 9.
Bullish Signals
MetLife raised quarterly dividend 4.4% to 59.25 cents.
Annualized yield is 3% at a $78.28 closing price.
Quarterly dividends grew 8.1% annually since 2011.
Management shows confidence with increased capital returns.
Bullish Signals
MetLife raised its quarterly dividend by 4.4% to 59.25 cents a share, from 56.75 cents.
The annualized dividend now stands at $2.37 per share, offering a 3% yield based on the latest closing price of $78.28.
The company has demonstrated consistent growth by increasing its quarterly dividend at an 8.1% compound annual growth rate since 2011.
This positive financial signal indicates strong management confidence and capital returns to shareholders.
Risk Factors
The article reports an increase in dividends, which does not contain any specific negative aspects, risks, or downside catalysts related to the provided content.
New York-based MetLife, Inc. (MET) is preparing to announce its fiscal first-quarter earnings for 2026, with analysts projecting the company will beat consensus estimates based on recent performance trends. MET is a global financial services provider operating across insurance, annuities, employee benefits, and asset management, with a current market capitalization of $46.4 billion. Regarding the upcoming Q1 report, Wall Street expects the company to report a diluted profit of $2.21 per share, representing a 12.8% increase from $1.96 per share in the same quarter last year. Over the past four quarters prior to this announcement, MetLife has consistently beaten estimates in two instances while missing forecasts on two others, suggesting a volatile but generally positive analyst reception.
For full-year outlooks, analysts anticipate MET will report earnings per share (EPS) of $9.86 for the current fiscal year, which would mark an 10.9% rise from the $8.89 reported in fiscal 2025. Growth is projected to continue into the next fiscal period, with EPS expected to reach $10.99 in fiscal 2027, reflecting an 11.5% year-over-year increase. The company's stock has historically underperformed broader market indices, posting only an 8.7% gain over the past 52 weeks compared to the S&P 500 Index’s 36.1% rally and the State Street Financial Select Sector SPDR ETF’s (XLF) 16.6% return. Most recently, following its Q4 results on February 4, shares rose 1.4% after adjusted EPS of $2.49 and a 27.6% revenue increase to $23.8 billion were reported.
Investor sentiment remains favorable, with MET receiving an overall "Moderate Buy" rating from the analyst community. Of the 19 analysts covering the stock, 11 maintain a "Strong Buy" stance, while one suggests a "Moderate Buy" and seven recommend a "Hold." The average analyst price target is set at $91.44, which implies approximately 23% upside from current trading levels. Beyond earnings, other market updates include potential calendar reminders for April regarding major consumer stocks and commentary on housing redesigns by Mark Cuban, though these are tangential to MetLife's specific financial performance.
📈 MetLife (MET) Q1 2026 diluted EPS estimated at $2.21, a 12.8% year-over-year increase.
💰 Full-year analysts project $9.86 EPS for 2026 and $10.99 for 2027 with double-digit growth.
⚠️ Stock gained only 8.7% over S&P 500's 36.1% gain during past 52 weeks.
🏦 Market cap stands at $46.4 billion with average price target of $91.44 (23% upside).
⚖️ Analyst sentiment is bullish with split ratings including multiple strong buys and seven holds.
📈 MetLife (MET) is expected to report fiscal Q1 2026 earnings with diluted EPS of $2.21, representing a 12.8% increase from the prior year quarter.
💰 Full-year analysts estimate MET will post $9.86 EPS in fiscal 2026 and $10.99 EPS for fiscal 2027, reflecting double-digit projected growth.
📊 Previous Q4 2025 results showed adjusted EPS of $2.49 and revenue growth of 27.6% to $23.8 billion following the Feb. 4 announcement.
📉 MET stock has underperformed the S&P 500 and Financial Select Sector ETF over the past 52 weeks, gaining only 8.7% versus 36.1% and 16.6% respectively.
🏦 The company provides insurance, annuities, employee benefits, and asset management services globally with a market cap of $46.4 billion.
⚖️ Analyst sentiment is generally bullish with an average price target of $91.44, implying roughly 23% upside from current levels.
📝 Of 19 analysts covering MET, the ratings are split between multiple strong buy recommendations and seven holds.
❗ Previous quarters show mixed analyst performance records, with MET beating consensus in two quarters while missing forecasts in two others.
Bullish Signals
Profit expected to rise 12.8% YoY to $2.21 per share in Q1 2026.
Full-year EPS forecast increases 10.9% to $9.86, up from fiscal 2025 levels.
Long-term growth visible with EPS projected at $10.99 by fiscal 2027.
Recent Q4 adjusted EPS jumped 19.1% YoY to $2.49 with revenue up 27.6%.
Analysts see 23% upside potential with average price target of $91.44.
Majority of 19 analysts advise 'Strong Buy' rating for MetLife stock.
Risk Factors
MET stock gained only 8.7% versus S&P 500's 36.1% in 52 weeks.
Stock lagged XLF ETF's 16.6% returns over the last year.
Mixed analyst consensus: seven rate as Hold with lingering uncertainty.
Inconsistent performance: beat forecasts only two of four last quarters.
Bullish Signals
MetLife expects fiscal first-quarter 2026 profit of $2.21 per share, representing a strong 12.8% increase from $1.96 per share in the same quarter last year.
For the full fiscal year, analysts forecast MET to report EPS of $9.86, which is up 10.9% from $8.89 in fiscal 2025.
Long-term growth is visible with EPS projected to rise 11.5% year over year to $10.99 in fiscal 2027.
Recent Q4 performance demonstrated robust momentum, with adjusted EPS jumping 19.1% year over year to $2.49 and revenue surging 27.6% to $23.8 billion.
The analyst consensus is moderately bullish with an average price target of $91.44, indicating a potential upside of 23% from current levels.
Of the 19 analysts covering MetLife, 11 advise a 'Strong Buy' rating and only 7 give a 'Hold', reflecting positive sentiment.
Risk Factors
MET stock has underperformed the S&P 500 Index's 36.1% gains over the past 52 weeks, rising only 8.7% during the same period.
The stock also lagged behind the State Street Financial Select Sector SPDR ETF's (XLF) 16.6% returns over the last year.
Analyst consensus is mixed with seven analysts rating the stock a 'Hold,' signaling lingering uncertainty despite overall bullish sentiment.
Historical performance shows inconsistency, with the company beating forecasts in only two of its last four quarters while missing on two others.
MetLife's chief market strategist Drew Matus joined CNBC's "Money Movers" to discuss the implications of recent jobs data on Federal Reserve policy. Matus argued that the latest employment figures significantly constrain the Fed's ability to adjust interest rates, making a market reaction more predictable and difficult than previous expectations suggested. He emphasized that the data is creating a rigid framework for central bank decision-making, limiting how quickly or aggressively the Fed can pivot its monetary stance based on traditional economic indicators.
The segment highlighted broader market sentiment regarding inflation and rate cuts, with OnePoint BFG's Peter Boockvar forecasting 3-4% inflation through year-end and expecting only one "symbolic" rate cut in that timeframe. Morgan Stanley CIO Mike Wilson noted that the current market playbook now resembles pre-war dynamics, suggesting a shift in how investors are pricing economic outcomes relative to geopolitical and domestic stability factors. Meanwhile, TWG Global’s Amos Hochstein commented on international tensions, stating it is "fantasy" to believe Iran will relinquish control over the Strait of Hormuz, underscoring persistent geopolitical risks affecting global trade flows.
Other key themes from the episode included domestic policy efforts and economic pain points. Representative Brian Fitzpatrick spoke on bipartisan initiatives aimed at funding the Department of Homeland Security, reflecting a focus on legislative solutions for border and security challenges. Additionally, CFR's Michael Froman assessed the situation involving Iran, noting that the U.S. underestimated "how much pain" Tehran is willing to endure in potential conflicts. These perspectives collectively paint a complex economic landscape where strong labor data restricts policy flexibility while external threats and inflation expectations continue to shape market strategy for 2026.
📉 Strong jobs data limits Fed interest rate adjustment flexibility.
🤔 Morgan Stanley sees current markets mirroring pre-war conditions.
⚠️ Iran is unlikely to relinquish Strait of Hormuz control.
📊 Peter Boockvar forecasts 3-4% inflation and one rate cut.
🗳️ Bipartisan efforts underway to fund Department of Homeland Security.
📉 Jobs data has limited the Federal Reserve's ability to adjust interest rates effectively.
🤔 Drew Matus from MetLife notes that strong employment figures complicate Fed reaction plans.
💼 Morgan Stanley CIO Mike Wilson suggests the current market playbook mirrors pre-war conditions.
⚠️ Amos Hochstein warns it is unrealistic to expect Iran to relinquish control of the Strait.
📊 Peter Boockvar forecasts 3-4% inflation and a single symbolic rate cut by year-end.
🗳️ Representative Brian Fitzpatrick discussed bipartisan efforts to fund the Department of Homeland Security.
⚔️ Michael Froman states the U.S. underestimated Iran's willingness to endure significant pain.
Bullish Signals
MetLife: Strong jobs data limits Fed's quick rate cuts. Stability expected.
Morgan Stanley: Markets resemble pre-war levels, signaling resilience.
OnePoint BFG: One symbolic rate cut anticipated despite inflation.
Market depends on 3-4% inflation and one symbolic rate cut.
Bullish Signals
MetLife's Drew Matus highlights that robust jobs data limits the Federal Reserve's ability to cut rates quickly, suggesting a stable economic environment.
Morgan Stanley CIO Mike Wilson compares current market conditions to pre-war levels, indicating resilience and familiarity for investors.
OnePoint BFG's Peter Boockvar expects one 'symbolic' rate cut by year-end despite 3-4% inflation, showing potential policy support for growth.
Rep. Brian Fitzpatrick is engaged in bipartisan efforts to fund the Department of Homeland Security, fostering political stability.
Risk Factors
The jobs data makes it hard for the Fed to react.
The market outlook relies on expectations of only 3-4% inflation, with investors expecting merely one 'symbolic' rate cut by year-end.
MetLife (MET) has recently attracted investor attention following share price volatility, recording a 0.6% decline over the past day and a modest gain over the past week. However, broader performance metrics indicate mixed short-term trends, with both the 90-day and year-to-date share price returns showing an 11.95% decline in contrast to a stronger 3-year total shareholder return of 31.37%. Currently trading at $70.72, the stock presents an indicated intrinsic value discount of 51.65% against an average analyst target price of $90.50, leading Simply Wall St to frame the current valuation primarily as earnings-driven rather than sentiment-driven.
The analysis suggests MetLife is undervalued with a fair value target of $90.50, supported by strong, sustained premium and sales growth in high-potential international markets including Asia, Latin America, and EMEA. This long-term growth potential is positioned to capitalize on growing middle-class wealth and increased insurance penetration, which supports robust revenue and top-line expansion. The fair value narrative relies on a detailed playbook blending steady top-line expansion, firmer profit margins, and disciplined capital use through future buybacks rather than aggressive blue sky forecasts.
Despite the undervalued stance, the investment thesis carries specific risks that could alter the valuation dynamics. The primary concerns include interest rate volatility that could pressure investment margins, as well as commercial mortgage loan losses and reserve builds that may strain earnings and capital reserves. Simply Wall St advises investors to weigh these factors carefully and consult a full narrative to understand the forecasts behind the fair value calculation, noting that this analysis uses historical data and analyst forecasts without constituting financial advice or accounting for the latest price-sensitive announcements.
💰 Analyst target price of $90.50 suggests current market discount.
⚠️ Key risks include interest rate volatility and mortgage loan losses.
📉 MetLife (MET) stock declined 0.6% over the past day and gained slightly over the past week amid recent volatility.
⚠️ The stock has experienced weak share price returns over recent months with a 11.95% drop in the past 90 days and year-to-date.
📈 Long-term performance remains positive with a 3-year total shareholder return of 31.37%.
💰 MetLife is trading at $70.72 against an indicated intrinsic value discount of 51.65%.
🎯 The stock trades below the average analyst target price of $90.50.
🌏 Strategic growth opportunities exist in high-potential international markets like Asia, Latin America, and EMEA.
💵 The fair value model assumes disciplined capital use, ongoing buybacks, and steady top-line expansion rather than aggressive forecasts.
⚠️ Risks include interest rate volatility impacting investment margins and potential commercial mortgage loan losses.
📊 Simply Wall St's analysis concludes MetLife is currently undervalued with a fair value of $90.50.
💡 Investors are encouraged to scan broader screens for 20 founder-led companies, 62 high quality undervalued stocks, and 12 dividend fortresses.
📝 This article serves as general commentary based on historical data and analyst forecasts and is not financial advice.
Bullish Signals
MetLife's 3-year TSR of 31.4% highlights strong underlying value despite recent decline.
Stock trades at a 51.65% discount to $90.50 fair value, offering a compelling buy.
Premium and sales growth in Asia, Latin America, and EMEA support long-term revenue expansion.
Disciplined capital use and buybacks will drive top line growth and firmer margins.
Risk Factors
Input appears empty or invalid. Please provide actual content to summarize.
Bullish Signals
MetLife's 3-year total shareholder return of 31.37% significantly outperforms its recent short-term decline, highlighting strong underlying long-term value.
The stock trades at an indicated intrinsic value discount of 51.65% below a fair value target of $90.50, presenting a compelling buying opportunity.
Strong sustained premium and sales growth in high-potential international markets including Asia, Latin America, and EMEA positions the company for robust long-term revenue expansion.
The company's playbook assumes disciplined capital use and ongoing buybacks to support steady top line expansion and firmer profit margins.
MetLife Inc. (MET) saw its shares rise 1.03% to close at $69.89 on Tuesday, continuing a streak of two consecutive days of gains for the insurer. However, this performance was overshadowed by an underwhelming comparison against rival companies and the broader market context, which remained weak throughout the day. The trading session proved rough overall for equity markets, with the S&P 500 Index (SPX) declining 0.37% to finish at 6,556.37, while the Dow Jones Industrial Average (DJIA) slipped 0.18% to settle at 46,124.06. Despite the challenging environment for the general market, MetLife managed to post gains, though they lagged behind its competitors in relative terms.
The article highlights that while MetLife's stock advanced, it was part of an all-around rough trading session characterized by declines in major benchmarks. MarketWatch notes that this report is supported by world-class market data from Dow Jones and FactSet, with content automation assistance provided by Automated Insights. The summary emphasizes the specific performance metrics for the day, including the precise closing price of MetLife at $69.89 and the percentage increase of 1.03%.
No further operational details or financial statements are provided in this brief update beyond the daily stock movement and broader market index changes. The text includes standard data disclaimers from MarketWatch, noting that intraday data is delayed by at least 15 minutes or subject to exchange requirements, and historical end-of-day data is sourced from FACTSET. All quotes reflect trades reported through Nasdaq in local exchange time, underscoring the limitations of the real-time data used for the report. The article is published on March 24, 2026, at 4:51 p.m. ET, and carries copyright ownership by MarketWatch, Inc.
🔁 This marks MetLife's second consecutive day of gains.
📉 MetLife Inc. (MET) shares rose 1.03% to $69.89 on Tuesday, outperforming the broader market decline.
📊 Despite MET's gains, the stock underperformed competitors as the S&P 500 fell 0.37% and the Dow Jones Industrial Average dropped 0.18%.
📈 This marks MetLife's second consecutive day of positive trading activity.
Bullish Signals
MetLife Inc. (MET) shares advanced 1.03% to $69.89 on Tuesday, posting gains even as the broader market fell.
This marks the stock's second consecutive day of gains, demonstrating resilience despite a rough trading session for the S&P 500 and Dow Jones Industrial Average.
Risk Factors
MetLife stock advanced 1.03% on Tuesday, but still underperformed relative to competitors despite overall market gains.
Shares traded at $69.89 during a rough trading session where the broader market saw declines, indicating weaker sentiment compared to peers.
Despite two consecutive days of gains, the company failed to capture significant upside during an otherwise difficult market environment, suggesting limited investor enthusiasm.
Your Privacy
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Measure audience engagement and site statistics to understand how our services are used (Google Analytics)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
You can accept all cookies or configure your preferences. You can change them at any time via the "Manage Cookies" link in the footer.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Analytics cookies
Help us understand how visitors interact with our website using Google Analytics. These cookies collect information anonymously.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
